ライフサイエンスコーパス: core needle biopsy

1 without metastatic disease and diagnosed by core needle biopsy.

2 aling malignant changes in the vicinity of a core needle biopsy.

3 y of nucleic acid yields from imaging-guided core needle biopsy.

4 nding of diagnostic techniques, particularly core needle biopsy.

5 ally as atypical ductal hyperplasia (ADH) by core needle biopsy.

6 ith 43 benign papillary lesions diagnosed at core-needle biopsy.

7 rformed on tissue obtained with image-guided core-needle biopsy.

8 scopic findings at the time of lumpectomy or core-needle biopsy.

9 %) patients, open biopsy was performed after core-needle biopsy.

10 ter numbers of viable cells when compared to core needle biopsies.

11 After US-guided core-needle biopsy, 115 (58%) of 198 patients were treat

12 ) compared with those with ADH diagnosed via core needle biopsy (5%; 95% CI, 2.2%-8.9%).

13 agnostic yield (71.5% [40/56]) compared with core-needle biopsy (50% [17/34] P = .04) and fine needle

14 were almost three times as high as those for core-needle biopsy ($698 vs $243).

15 Among 572 scheduled stereotactic core-needle biopsies, 89 cases (16%) in 88 patients were

16 CT-guided transsternal approach for coaxial core-needle biopsy allows safe access to masses in vario

17 , or high-risk (for cancer) breast tissue at core-needle biopsy and had undergone subsequent surgery

18 c accuracy of other interventions, including core-needle biopsy and needle-localized open surgical bi

19 uracy of US-guided FNA is similar to that of core needle biopsy, and there were no complications in t

20 graphic findings, the histologic findings at core-needle biopsy, and the findings at subsequent surgi

21 Definitive surgical, core-needle biopsy, and/or follow-up information was ava

22 Patients underwent pretreatment core needle biopsy; archival tumor samples were also obt

23 CT and OCM, which has the potential to guide core needle biopsies, assess surgical margins, and evalu

24 Percutaneous core-needle biopsy can be an effective alternative to op

25 e compared with the Gleason score (GS) after core needle biopsy (CNB) in patients with low, medium an

26 Percutaneous core needle biopsy (CNB) is optimal for minimizing surge

27 ns (FELs) are a common histologic finding on core needle biopsy (CNB) of the breast.

28 Core needle biopsy (CNB) sampling is known to be inexpen

29 of columnar cell lesions (CCLs) in a breast core needle biopsy (CNB).

30 ation biopsies (FNAB) controlled with CT and core-needle biopsy (CNB) under real-time CT fluoroscopy

31 Low-strength evidence showed that core-needle biopsies conducted under stereotactic guidan

32 Stereotactic core needle biopsy decreases the cost of diagnosis, but

33 Studies that compared core-needle biopsy diagnoses with open surgical diagnose

34 However, despite stereotactic guidance, core needle biopsy fails to retrieve microcalcifications

35 he MR imaging-guided 9-gauge vacuum-assisted core-needle biopsy findings of 85 lesions in 75 patients

36 scape for spectroscopic validation of breast core needle biopsy for detection of microcalcifications

37 wed 101 patients who underwent transthoracic core needle biopsy for the KEYNOTE-001 (MK-3475) clinica

38 ide expression profiling was performed on 50 core needle biopsies from 18 breast cancer patients usin

39 Multisite stereotactic core needle biopsy had a positive effect on patient care

40 vity, specificity, and accuracy of US-guided core needle biopsy in differentiating benign from malign

41 Core-needle biopsy in comparison to fine-needle aspirati

42 he sensitivity, specificity, and accuracy of core-needle biopsy in the detection of malignant neoplas

43 to 2012, the proportion of ADH diagnosed by core needle biopsy increased from 21% to 77%.

44 Core needle biopsy increases patient satisfaction and re

45 Conclusion Image-guided transthoracic core needle biopsy is an effective method for obtaining

46 Multisite stereotactic core needle biopsy is feasible, safe, and may influence

47 Stereotactic core needle biopsy is the diagnostic procedure of choice

48 ast lesions is necessary before stereotactic core-needle biopsy is scheduled.

49 Large-core needle biopsy (LCNB) has become an alternative to s

50 Stereotactic, 14-gauge, automated, large-core needle biopsy (LCNB) was performed in 483 consecuti

51 At core-needle biopsy, lesions were diagnosed as papilloma

52 At MR imaging-guided core-needle biopsy, malignancy was identified in 52 (61%

53 of metallic clips placed during stereotactic core-needle biopsy may differ substantially from the loc

54 th fine-needle aspiration (n = 55), 14-gauge core-needle biopsy (n = 81), or both (n = 14).

55 Tissue collected by core needle biopsy of a left internal jugular lymph node

56 atus in recurrent disease is usually made by core needle biopsy of a single lesion, which may not rep

57 Twenty-five patients underwent stereotactic core needle biopsy of more than one site.

58 Ultrasound-guided core needle biopsy of the breast mass diagnoses an invas

59 Findings at 209 consecutive core-needle biopsies of lesions of the thyroid gland in

60 /METHODS: From January, 2012 to May 2013, 76 core-needle biopsies of lung and mediastinum tumors were

61 d needle track created by stereotactic large-core-needle biopsy of the breast.

62 rly selected cases by those performing large-core-needle biopsy of the breast.

63 Core-needle biopsy of the renal cortex obtained during s

64 US-guided core-needle biopsy of the thyroid gland is a safe outpat

65 Diagnosis of ADH on core needle biopsy or excisional biopsy in women undergo

66 gh risk for breast cancer and should undergo core-needle biopsy or needle localization with surgical

67 ances in diagnostic techniques, specifically core needle biopsies performed under mammographic and ul

68 on radiographs of the specimens obtained at core needle biopsy performed through the region of color

69 st lesion, in real-time, during stereotactic core needle biopsy procedures.

70 Stereotactic- and ultrasonography-guided core-needle biopsy procedures seem to be almost as accur

71 In 105 (74%) patients, core-needle biopsy results were concordant with results

72 In 36 (26%) patients, inaccurate core-needle biopsy results were obtained: In nine, resul

73 Ultrasound-guided core needle biopsy revealed an infiltrating ductal carci

74 Overall mean number of core needle biopsy samples obtained was 7.9 samples.

75 ul for regular quantification of steroids in core needle biopsy samples of breast tissue to inform do

76 indings were compared with histopathology of core needle biopsy samples or with ultrasound follow-up

77 to whole sections, paired surgical resection/core needle biopsy samples, and paired samples from 69 p

78 psy techniques include stereotactic 14-gauge core-needle biopsy (SC bx), stereotactic 11-gauge suctio

79 aluated the differences between stereotactic core needle biopsy (SCNBx) and needle localization surgi

80 hat papillary lesions diagnosed as benign at core-needle biopsy should be surgically excised because

81 Large-core needle biopsy showed diffuse calcifications within

82 risk for severe complications is lower with core-needle biopsy than with open surgical procedures (<

83 hic lesions entirely removed at percutaneous core needle biopsy that required wider excision underwen

84 ples and 177 tissue samples (ie, resected or core-needle biopsied tissues).

85 ogic findings, fibrin bands or collagen, and core needle biopsy tract at microscopy.

86 to the great increase in the utilization of core needle biopsies under mammographic and ultrasonogra

87 mizing nucleic acid yields in CT-guided lung core needle biopsies used for genomic analysis, there sh

88 Cost savings of stereotactic core needle biopsy vary in subgroups of patients defined

89 e cancer associated with ADH diagnosed using core needle biopsy vs excisional biopsy.

90 uly 1992 through February 1995, stereotactic core needle biopsy was performed in 356 women with 405 n

91 Core-needle biopsy was performed at a tertiary care inst

92 mmography, fine-needle aspiration biopsy, or core-needle biopsy was performed before a definitive dia

93 For each lesion, image-guided core-needle biopsy was performed immediately after PET m

94 vity, specificity, and accuracy of US-guided core-needle biopsy were calculated.

95 hom breast cancer was initially diagnosed by core-needle biopsy were more likely than women with canc

96 Five patients also underwent core-needle biopsy with a coaxially introduced 20-gauge

97 One hundred eleven cases of core-needle biopsy with clip deployment were reviewed.

98 d ratio (HR) of 3.0 (95% CI, 2-4.5) and, via core needle biopsy, with an adjusted HR of 2.2 (95% CI,